Bassand JP - Search Results

1

Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis.

Mirshahi M, Soria C, Soria J, Mirshahi M, Faivre R, Kieffer Y, Bassand JP, Toulemonde F, Caen J. Mirshahi M, et al. Among authors: bassand jp. Thromb Res. 1988 Aug 1;51(3):295-302. doi: 10.1016/0049-3848(88)90106-5. Thromb Res. 1988. PMID: 3175985

2

Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.

Faivre R, Neuhart E, Mirshahi M, Mirshahi M, Soria C, Soria J, Bassand JP, Caen JP, Maurat JP. Faivre R, et al. Among authors: bassand jp. Semin Thromb Hemost. 1989 Oct;15(4):435-9. doi: 10.1055/s-2007-1002743. Semin Thromb Hemost. 1989. PMID: 2554504 No abstract available.

3

Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.

Faivre R, Mirshahi M, Ducellier D, Soria C, Soria J, Mirshahi M, Kieffer Y, Bassand JP, Caen J, Maurat JP. Faivre R, et al. Among authors: bassand jp. Thromb Res. 1988 May 15;50(4):583-9. doi: 10.1016/0049-3848(88)90206-x. Thromb Res. 1988. PMID: 3413720 No abstract available.

4

[Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].

Faivre R, Neuhart E, Kieffer Y, Bassand JP, Maurat JP. Faivre R, et al. Among authors: bassand jp. J Mal Vasc. 1987;12 Suppl B:145-6. J Mal Vasc. 1987. PMID: 2834488 Clinical Trial. French.

5

[A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study].

Faivre R, Neuhart Y, Kieffer Y, Apfel F, Magnin D, Didier D, Toulemonde F, Bassand JP, Maurat JP. Faivre R, et al. Among authors: bassand jp. Presse Med. 1988 Feb 13;17(5):197-200. Presse Med. 1988. PMID: 2965375 Clinical Trial. French.

6

A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.

Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Soria J, Soria C, Camez A, Mirshahi MC, Bassand JP. Schiele F, et al. Among authors: bassand jp. Thromb Haemost. 1994 May;71(5):558-62. Thromb Haemost. 1994. PMID: 8091380 Clinical Trial.

7

Low-molecular-weight heparin for deep venous thrombosis.

Faivre R, Neuhart E, Bassand JP, Maurat JP. Faivre R, et al. Among authors: bassand jp. JAMA. 1988 Nov 4;260(17):2507-8. JAMA. 1988. PMID: 2845162 No abstract available.

8

[Severe thrombopenia from heparin: value of the use of low molecular weight heparin. Apropos of 6 cases].

Faivre R, Kieffer Y, Bassand JP, Maurat JP. Faivre R, et al. Among authors: bassand jp. Arch Mal Coeur Vaiss. 1985 Jan;78(1):27-30. Arch Mal Coeur Vaiss. 1985. PMID: 3919676 French.

9

[Major thrombopenia induced by heparin treatment. Apropos of 8 cases].

Faivre R, Kieffer Y, Bassand JP, Maurat JP. Faivre R, et al. Among authors: bassand jp. Ann Med Interne (Paris). 1983;134(8):702-6. Ann Med Interne (Paris). 1983. PMID: 6666908 French.

10

[Treatment of deep venous thrombosis with fractions of low molecular weight heparin].

Faivre R, Ducellier D, Kieffer Y, Bassand JP, Maurat JP. Faivre R, et al. Among authors: bassand jp. Therapie. 1988 May;43(3):183-5. Therapie. 1988. PMID: 2844003 Clinical Trial. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters